3D Contrast Enhanced Acoustic Perfusion Imaging in Adult After Subarachnoid Hemorrhage
ESRIR
Pilot Study : Characterization of Early Brain Injury and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage by Ultrasound Localization Microscopy (ULM) 3D with an Experimental Medical Device (ESRIR)
2 other identifiers
interventional
15
1 country
1
Brief Summary
Aneurysmal subarachnoid hemorrhage (SAH) is a devastating form of stroke, with three major complications : early brain injury (EBI), vasospasm and delayed cerebral ischemia (DCI). Those patients are often given care in neurocritical care. Imaging is particularly useful to diagnose these complications. Brain imaging includes CT scan, MRI and arteriography which are not easily available and need an intrahospital transportation. Furthermore, intrahospital transportation of critically ill patients is associated with significant complications Here, investigators try to show that a new non-invasive bedside device, based on 3D enhanced ultrasonography, is able to detect principal arteries of anterior circulation of the brain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJanuary 27, 2025
July 1, 2024
10 months
July 10, 2024
January 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of a time-intensity curve (TIC) of contrast agent / Quality of signal
Mathematical models may be used to estimate blood flow parameters after the administration of microbubble contrast agents. A time-intensity curve (TIC) may be created to reflect the intravascular transit of the contrast agent. TICs reflect the average intensity in a region of interest, measured in absolute intensity units, over time in seconds. Plotting TIC in a given frame allows for quantification of various parameters, including time to peak, peak intensity, area under the curve, wash-in and wash-out time, and mean transit time. Some of these parameters, such as peak intensity and area under the curve, reflect local blood volume in the region of interest, whereas, other parameters (time to peak intensity, wash-in/wash-out time) are more reflective of blood flow.
day 0-2 / day 4-10 / day 11-14
Secondary Outcomes (3)
Agreement between data from 3D ultrasonography localizing miroscopy and clinical parameters of early brain injury, cerebral vasospam and delayed cerebral ischemia
day 0-2 / day 4-10 / day 11-14
Ability to detect principal arteries of anterior circulation
day 0-2 / day 4-10 / day 11-14
Variability of measurement
day 0-2 / day 4-10 / day 11-14
Study Arms (1)
Ultrasonography localizing microscopy 3D
EXPERIMENTALEnhanced (with Sonovue IV 2,4mL x2) transcranial ultrasonography
Interventions
3 bilateral transcranial enhanced (with Sonovue) ultrasonography per patient to visualize cranial arteries of the anterior circulation of the brain
Eligibility Criteria
You may qualify if:
- Admitted in neurologic ICU of the CHU Caen, Normandy, for a subarachnoid hemorrhage of the anterior circulation.
- Usable ultrasound temporal window.
- years old and more.
- Consent of the participant or the trusted person.
You may not qualify if:
- non-aneurysmal subarachnoid haemorrhage.
- Contraindication to ultrasound contrast agent Sonovue, including allergies to a compound.
- Uncontrolled systemic hypertension.
- Acute respiratory distress syndrome.
- Pregnancy or breastfeeding mother.
- Vulnerable person with guardianship or curatorship.
- Patient not affiliated to french social security system (Sécurité Sociale)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Caenlead
- European Research Councilcollaborator
Study Sites (1)
CAEN University Hospital
Caen, 14000, France
Related Publications (2)
Ghendon Y. WHO recommendation on potential use of new poliomyelitis vaccines. Dev Biol Stand. 1993;78:133-7; discussion 138-9.
PMID: 8388823BACKGROUNDShea SS, Selfridge-Thomas J. The ED nurse practitioner: pearls and pitfalls of role transition and development. J Emerg Nurs. 1997 Jun;23(3):235-7. doi: 10.1016/s0099-1767(97)90014-3. No abstract available.
PMID: 9283360BACKGROUND
Related Links
- Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
- SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
- Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage (PSAB)
- Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clément GAKUBA, PhD
CHU CAEN
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- The investigator and care provider can't see the imaging results.
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2024
First Posted
January 27, 2025
Study Start
May 1, 2024
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
January 27, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
IPD won't be shared with other researchers. Data will be collected in a data base with an authentification by password. The used system is in accordance with the french law, notably MR-01. Only permitted person will be given an access to the data base. Every connection to the data base will be recorded.